Home Data Calendar Blog

MRVI

Tables

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Weighted Average Number Of Diluted Shares Outstanding 131.65255.36255.29NA258.03112.2896.67NA253.92253.92253.92
Weighted Average Number Of Shares Outstanding Basic 131.54131.52131.49NA118.43112.2096.65NA253.92253.92253.92
Earnings Per Share Basic 0.340.540.510.430.460.440.247.220.120.000.09
Earnings Per Share Diluted 0.340.530.500.420.450.440.242.150.120.000.09

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Revenue From Contract With Customer Excluding Assessed Tax 191.26242.73244.29228.44204.81217.78148.2198.3587.8646.9150.98
Revenues 191.26242.73244.29228.44204.81217.78148.2198.3587.8646.9150.98
Cost Of Revenue 38.1837.5040.0340.6332.0537.5130.3723.3919.7621.2015.30
Costs And Expenses 74.3662.0376.9377.3647.9463.5355.7767.1142.1438.7816.16
Research And Development Expense 5.394.273.699.171.951.932.162.091.871.603.74
Selling General And Administrative Expense 30.8028.0633.2027.5525.1924.0923.2441.6220.5115.9916.13
Operating Income Loss 116.90180.70167.37151.09156.87154.2592.4431.2545.728.1234.82
Interest Expense 3.144.432.664.438.548.518.778.817.097.467.38
Interest Paid Net 5.284.761.374.207.487.607.959.517.635.546.24
Gains Losses On Extinguishment Of Debt 0.000.00-0.21NANANANANANANANA
Allocated Share Based Compensation Expense 4.744.313.632.233.572.382.2821.701.850.580.51
Income Tax Expense Benefit 14.1118.2719.9817.5818.8411.3913.710.37-0.36-0.773.63
Income Taxes Paid 5.7212.940.915.907.486.362.731.50NANANA
Profit Loss 99.65156.72146.86126.24132.81134.3475.8511.4339.021.4423.88
Net Income Loss 44.4771.2466.8655.4454.2749.0823.2525.2138.951.4223.39
Comprehensive Income Net Of Tax 44.4771.2466.8655.4454.3149.0823.2525.2038.981.4323.32
Net Income Loss Available To Common Stockholders Basic 44.4771.2466.8655.4454.2749.0823.2523.3631.220.2122.33
Net Income Loss Available To Common Stockholders Diluted 44.49136.54127.96109.64115.1549.0923.2514.5531.220.2122.33

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Assets 2248.902171.802043.231918.281894.681601.251351.771270.69NANANA
Liabilities 1407.231398.011388.931372.911441.071268.111142.011115.94NANANA
Liabilities And Stockholders Equity 2248.902171.802043.231918.281894.681601.251351.771270.69NANANA
Stockholders Equity 503.76456.59382.56315.50302.64193.92112.6188.51NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Assets Current 835.53759.38619.13740.04687.48644.49425.54331.60NANANA
Cash 617.45550.68431.47551.27547.90374.71247.68236.18NANANA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 617.45550.68431.47551.27547.90374.71247.68236.18124.8884.4676.75
Accounts Receivable Net Current 114.07120.35120.36117.5165.9483.53121.8251.02NANANA
Inventory Net 62.4260.1151.4151.5656.2547.7847.1333.30NANANA
Prepaid Expense And Other Assets Current 23.4319.6615.9019.7017.3913.438.9211.10NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Amortization Of Intangible Assets 6.256.255.533.654.605.045.045.165.045.045.08
Property Plant And Equipment Net 48.4246.9647.7046.33108.32104.75105.13101.31NANANA
Goodwill 283.54283.54283.54152.77152.77152.77224.28224.28NANANA
Intangible Assets Net Excluding Goodwill 222.90229.15235.41117.57121.22125.12172.62177.66NANANA
Finite Lived Intangible Assets Net 222.90229.15235.41117.57121.22125.12172.62177.66NANANA
Other Assets Noncurrent 87.4072.4264.2453.454.114.034.304.16NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Liabilities Current 115.66112.5386.6793.78114.35164.77165.25130.78NANANA
Long Term Debt Current 5.445.445.446.006.006.006.006.00NANANA
Accounts Payable Current 9.4623.2710.388.158.9211.709.818.17NANANA
Other Accrued Liabilities Current 12.019.06NA5.23NA5.38NA6.15NANANA
Accrued Liabilities Current 60.1943.6432.4134.5731.4224.7928.9738.55NANANA
Contract With Customer Liability Current 5.825.433.6910.2166.72109.49119.1778.06NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Long Term Debt 528.26529.10529.94530.59531.58532.58533.59534.61NANANA
Long Term Debt Noncurrent 522.82523.65524.50524.59525.58526.58527.59528.61NANANA
Minority Interest 337.91317.20271.74229.86150.98139.2297.1466.23NANANA
Other Liabilities Noncurrent 57.5250.5966.5241.071.551.062.312.23NANANA
Operating Lease Liability Noncurrent 43.79NANA40.91NANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Stockholders Equity 503.76456.59382.56315.50302.64193.92112.6188.51NANANA
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 841.67773.79654.30545.36453.62333.14209.76154.75NANANA
Additional Paid In Capital 134.08131.37128.58128.39172.61118.2185.9885.12NANANA
Retained Earnings Accumulated Deficit 367.13322.66251.42184.56127.4573.1824.100.85NANANA
Minority Interest 337.91317.20271.74229.86150.98139.2297.1466.23NANANA
Stock Issued During Period Value New Issues 0.031.110.030.890.000.79NANANANANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 4.744.313.632.233.572.382.280.97NANANA
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 36.5442.6539.8947.2950.0033.0823.138.170.120.19NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Net Cash Provided By Used In Operating Activities 110.06164.28162.3058.17105.86165.8338.7279.4351.4311.629.71
Net Cash Provided By Used In Investing Activities -5.85-1.66-241.58-5.66118.55-4.20-3.03-8.85-10.09-3.0628.07
Net Cash Provided By Used In Financing Activities -37.44-43.41-40.52-49.00-51.50-34.35-24.2040.67-0.94-0.8614.34

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Net Cash Provided By Used In Operating Activities 110.06164.28162.3058.17105.86165.8338.7279.4351.4311.629.71
Net Income Loss 44.4771.2466.8655.4454.2749.0823.2525.2138.951.4223.39
Profit Loss 99.65156.72146.86126.24132.81134.3475.8511.4339.021.4423.88
Increase Decrease In Accounts Receivable -5.830.122.2251.54-17.62-34.3470.81-22.2845.68-0.3410.09
Increase Decrease In Inventories 2.318.70-1.20-4.698.194.2513.836.714.462.565.37
Increase Decrease In Accounts Payable -4.424.361.95-0.87-2.542.191.901.05-3.290.023.40
Deferred Income Tax Expense Benefit 9.2312.8613.2217.4711.236.4511.76-4.19-0.000.00-1.27
Share Based Compensation 4.744.313.632.233.572.382.2821.701.850.580.51
Amortization Of Financing Costs 0.720.710.700.680.680.670.650.530.430.430.43

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Net Cash Provided By Used In Investing Activities -5.85-1.66-241.58-5.66118.55-4.20-3.03-8.85-10.09-3.0628.07
Payments To Acquire Property Plant And Equipment 6.471.662.755.661.414.203.588.8510.093.063.41

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Net Cash Provided By Used In Financing Activities -37.44-43.41-40.52-49.00-51.50-34.35-24.2040.67-0.94-0.8614.34

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31
Revenues 191.26242.73244.29228.44204.81217.78148.2198.3587.8646.9150.98
Intersegment Elimination 0.00-0.01NA-0.05-0.15-0.22-0.24-0.20-0.36-0.31-0.40
Operating 191.26242.74NANA204.96217.99NANANANANA
Operating, Biologics Safety Testing 16.3817.4820.6415.9316.6318.2117.6514.1214.1112.3614.29
Operating, Nucleic Acid Production 174.88225.25223.65212.56183.06192.74124.1777.9568.0230.7330.89
Biologics Safety Testing 16.3817.4820.6415.9316.6318.2117.6514.1214.1112.3614.29
Nucleic Acid Production 174.88225.25223.65212.51182.90192.52123.9377.7567.6630.4230.49
11.4735.3421.2026.7611.5729.3415.9813.798.8610.2910.23
97.7189.1986.9478.5383.8976.3578.3042.0346.5828.3133.42
Latin And Central America 0.250.160.110.160.220.250.220.140.070.150.12
EMEA 81.82118.04136.05122.99109.13111.8453.7242.4032.348.167.21
, Biologics Safety Testing 5.545.618.336.635.447.676.744.594.203.595.56
, Nucleic Acid Production 5.9329.7412.8720.145.3320.767.888.153.765.983.56
, Biologics Safety Testing 6.587.177.525.637.206.446.415.576.045.065.12
, Nucleic Acid Production 91.1382.0279.4272.9073.6265.7268.1332.6936.8120.8424.87
Latin And Central America, Biologics Safety Testing 0.190.130.100.140.170.200.150.080.040.110.07
Latin And Central America, Nucleic Acid Production 0.070.040.010.020.020.000.020.00-0.000.010.01
EMEA, Biologics Safety Testing 4.074.584.703.543.813.904.353.893.833.603.54
EMEA, Nucleic Acid Production 77.75113.46131.35119.45103.93106.0547.9036.9127.083.602.05
Revenue From Contract With Customer Excluding Assessed Tax 191.26242.73244.29228.44204.81217.78148.2198.3587.8646.9150.98
Intersegment Elimination 0.00-0.01NA-0.05-0.15-0.22-0.24-0.20-0.36-0.31-0.40
Operating 191.26242.74NANA204.96217.99NANANANANA
Operating, Biologics Safety Testing 16.3817.4820.6415.9316.6318.2117.6514.1214.1112.3614.29
Operating, Nucleic Acid Production 174.88225.25223.65212.56183.06192.74124.1777.9568.0230.7330.89
Biologics Safety Testing 16.3817.4820.6415.9316.6318.2117.6514.1214.1112.3614.29
Nucleic Acid Production 174.88225.25223.65212.51182.90192.52123.9377.7567.6630.4230.49
11.4735.3421.2026.7611.5729.3415.9813.798.8610.2910.23
97.7189.1986.9478.5383.8976.3578.3042.0346.5828.3133.42
Latin And Central America 0.250.160.110.160.220.250.220.140.070.150.12
EMEA 81.82118.04136.05122.99109.13111.8453.7242.4032.348.167.21
, Biologics Safety Testing 5.545.618.336.635.447.676.744.594.203.595.56
, Nucleic Acid Production 5.9329.7412.8720.145.3320.767.888.153.765.983.56
, Biologics Safety Testing 6.587.177.525.637.206.446.415.576.045.065.12
, Nucleic Acid Production 91.1382.0279.4272.9073.6265.7268.1332.6936.8120.8424.87
Latin And Central America, Biologics Safety Testing 0.190.130.100.140.170.200.150.080.040.110.07
Latin And Central America, Nucleic Acid Production 0.070.040.010.020.020.000.020.00-0.000.010.01
EMEA, Biologics Safety Testing 4.074.584.703.543.813.904.353.893.833.603.54
EMEA, Nucleic Acid Production 77.75113.46131.35119.45103.93106.0547.9036.9127.083.602.05

Plots across concepts


IncomeStatement
Comprehensive Income Net Of Tax
Expenses
Other Nonoperating Income Expense
Balance Sheet
Operating Lease Right Of Use Asset
Assets
Property Plant And Equipment Net
Current Assets
Prepaid Expense And Other Assets Current
NonCurrent Assets
Property Plant And Equipment Net
Liabilities
Liabilities Current
Current Liabilities
Long Term Debt Current
Noncurrent Liabilities
Operating Lease Liability Noncurrent
Stockholders Equity
Additional Paid In Capital
CashFlow
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInOperatingActivities
Increase Decrease In Accounts Receivable
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInFinancingActivities
Net Cash Provided By Used In Financing Activities
Shares
Weighted Average Number Of Shares Outstanding Basic
OperatingLeaseLiability
Operating Lease Liability Current
FiniteLivedIntangibleAssets
Finite Lived Intangible Assets Accumulated Amortization
InventoryNet
Inventory Finished Goods Net Of Reserves

Line plots across dimensions of each concept


us-gaap:CommonStockValue
us-gaap:StatementClassOfStock
(None,)
Common Stock Valueus-gaap: Statement Class Of Stock
us-gaap:SharesOutstanding
us-gaap:StatementClassOfStock, us-gaap:StatementEquityComponents
(None, 'us-gaap:CommonStock')
Shares Outstandingus-gaap: Statement Class Of Stock, us-gaap: Statement Equity Components
TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementGeographical
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Statement Geographical
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementBusinessSegments
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Statement Business Segments
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Consolidation Items, us-gaap: Statement Business Segments
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ConsolidationItems
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Consolidation Items
us-gaap:Revenues
us-gaap:StatementGeographical
(None,)
Revenuesus-gaap: Statement Geographical
us-gaap:Revenues
us-gaap:StatementBusinessSegments
(None,)
Revenuesus-gaap: Statement Business Segments
us-gaap:Revenues
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None)
Revenuesus-gaap: Consolidation Items, us-gaap: Statement Business Segments
us-gaap:Revenues
us-gaap:ConsolidationItems
(None,)
Revenuesus-gaap: Consolidation Items
us-gaap:ProfitLoss
us-gaap:StatementEquityComponents
(None,)
Profit Lossus-gaap: Statement Equity Components
us-gaap:AmortizationOfIntangibleAssets
us-gaap:IncomeStatementLocation
(None,)
Amortization Of Intangible Assetsus-gaap: Income Statement Location
us-gaap:FiniteLivedIntangibleAssetsNet
us-gaap:FiniteLivedIntangibleAssetsByMajorClass
(None,)
Finite Lived Intangible Assets Netus-gaap: Finite Lived Intangible Assets By Major Class
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
us-gaap:StatementClassOfStock, us-gaap:StatementEquityComponents
(None, 'us-gaap:CommonStock')
Stockholders Equity Including Portion Attributable To Noncontrolling Interestus-gaap: Statement Class Of Stock, us-gaap: Statement Equity Components
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
us-gaap:StatementEquityComponents
(None,)
Stockholders Equity Including Portion Attributable To Noncontrolling Interestus-gaap: Statement Equity Components
us-gaap:CommonStockValue
us-gaap:StatementClassOfStock
(None,)
Common Stock Valueus-gaap: Statement Class Of Stock
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
us-gaap:StatementEquityComponents
(None,)
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Valueus-gaap: Statement Equity Components
us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
us-gaap:StatementEquityComponents
(None,)
Minority Interest Decrease From Distributions To Noncontrolling Interest Holdersus-gaap: Statement Equity Components
us-gaap:ProfitLoss
us-gaap:StatementEquityComponents
(None,)
Profit Lossus-gaap: Statement Equity Components
us-gaap:Revenues
us-gaap:StatementGeographical
(None,)
Revenuesus-gaap: Statement Geographical
us-gaap:Revenues
us-gaap:StatementBusinessSegments
(None,)
Revenuesus-gaap: Statement Business Segments
us-gaap:Revenues
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None)
Revenuesus-gaap: Consolidation Items, us-gaap: Statement Business Segments
us-gaap:Revenues
us-gaap:ConsolidationItems
(None,)
Revenuesus-gaap: Consolidation Items
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementGeographical
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Statement Geographical
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementBusinessSegments
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Statement Business Segments
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Consolidation Items, us-gaap: Statement Business Segments
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ConsolidationItems
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Consolidation Items